Why the study?
Most episodes of venous thromboembolism occur in primary care, but no score had been developed to identify patients who may warrant antithrombotic prophylaxis.
A newly developed prediction model accurately predicts the risk of venous thromboembolism in primary care patients, potentially aiding in decisions regarding antithrombotic prophylaxis.
Supports VTE risk stratification in primary care; leaves open prospective validation and impact trials.
Background Most episodes of venous thromboembolism (VTE) occurred in primary care. To date, no score potentially able to identify those patients who may deserve an antithrombotic prophylaxis has been developed. Aim The objective of this study is to develop and validate a prediction model for VTE in primary care. Methods Using the Health Search Database, we identified a cohort of 1,359,880 adult patients between 2002 and 2013. The date of the first General Practitioner's (GP) visit was the cohort entry date. All VTE cases (index date) observed up to December 2014 were identified. The cohort was randomly divided in a development and a validation cohort. According to nested case-cohort analysis, up to five controls were matched to their respective cases on month and year of cohort entry and duration of follow-up. The score was evaluated according to explained variance (pseudo R2) as a performance measure, ratio of predicted to observed cases as model calibration and area under the curve (AUC) as discrimination measure. Results The score was able to explain 27.9% of the variation for VTE occurrence. The calibration measure revealed a margin of error lower than 10% in 70% of the population. In terms of discrimination, AUC was 0.82 (95% confidence interval: 0.82–0.83). Results of sensitivity analyses substantially confirmed these findings. Conclusion The present score demonstrated a very good accuracy in predicting the risk of VTE in primary care. This score may be therefore implemented in clinical practice so aiding GPs in making decision on patients potentially at risk of VTE.
No takes yet. Share an insight, caveat, or question.
Dentali et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: